Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Medicare may cover the implantation of a spinal cord stimulator as a therapy for chronic intractable pain. Chronic intractable pain refers to persistent pain that doesn’t respond to traditional ...

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

How Christopher Reeve’s legacy lives on in how spinal cord injury patients are treated today ...

Conventional treatments often have inconsistent efficacy and significant side effects. Combining spinal cord stimulation (SCS) with lidocaine patches may enhance pain relief by targeting central and ...

34,694 people played the daily Crossword recently. Can you solve it faster than others?34,694 people played the daily Crossword recently. Can you solve it faster than others?

Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...

A study published in Pain Reports adds a new piece to the puzzle, showing spinal disinhibition — disruption of the spinal cord’s inhibitory systems that modulate pain signals — in people ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).